| Financial Year |
March 31 2023 |
| Monetary Funds |
341,016,524.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
80,661,019.23 |
| Accounts Receivable |
502,235,426.08 |
| Advances to Suppliers |
25,015,654.90 |
| Other Receivables |
11,134,528.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
441,400,852.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
117,638.06 |
| Other Current Assets |
65,989,553.97 |
| Total Current Assets |
1,484,891,443.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
60,943.67 |
| Long-term Equity Investment |
181,588,383.49 |
| Investment Properties |
222,292,703.01 |
| Fixed Assetes |
1,234,500,270.29 |
| Under-construction Projects |
158,348,851.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,090,816.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,197,738.94 |
| Deferred Income Tax Assets |
101,512,035.05 |
| Other Non-Current Assets |
28,365,154.80 |
| Sub-Total of Non-Current Assets |
2,080,836,360.44 |
| Total Assets |
3,565,727,803.93 |
| Short-Term Loans |
127,057,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
250,029,642.23 |
| Accounts Payable |
446,594,626.85 |
| Accounts Received In Advance |
5,975,489.84 |
| Employee Compensation Payable |
41,046,578.13 |
| Taxes Payable |
9,237,429.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,443,108.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
98,499,288.43 |
| Other Current Liabilities |
70,041,237.42 |
| Sub-Total of Current Liabilities |
1,079,166,616.38 |
| Long-term Loans |
269,553,881.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,553,974.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
360,910,226.99 |
| Total Liabilities |
1,440,076,843.37 |
| Paid-In Capital(Or Share Stock) |
685,761,103.00 |
| Capital Surplus |
1,001,715,667.71 |
| Surplus Reserve |
39,716,748.12 |
| LESS:Treasury Stock |
4,160,000.00 |
| Undistributed Profits |
399,976,022.31 |
| Minority Stockholder's Interest |
6,251,531.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,119,399,429.44 |
| Owner's Equity（Stockholder's Equity） |
2,125,650,960.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,565,727,803.93 |
